Sign up for our newsletter and get 20% off your first order!

Daily Research Brief

BPC-157: Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18 , 185".

Pharmaceuticals (Basel, Switzerland) · 2025

3 minute read1/1/2025animal

We wish to thank the Authors of the comment for their interest in our manuscript [...].

What the study reported

How to read it carefully

Confirm the complete study design, intervention identity, population or model, outcomes, statistical context, and limitations in the linked source before approval.

Research context only. This brief summarizes a published source and does not establish clinical efficacy, safety, dosing, or suitability for human or veterinary use. Review the original paper before drawing conclusions.
Read the original source · Pharmaceuticals (Basel, Switzerland)
← Back to the newsletter